摘要
靶向治疗,基于根本的基因改变的癌症治疗,作为一种首选治疗方法迅速获得青睐。迄今为止,虽然天然产物是一种生物多样性非常丰富的候选药物的来源,但是只有少数的天然产物已经被证实为有效的癌症靶向治疗药物,这很大程度上是由于目前高通量筛选方法的不兼容性。在这篇文章中,我们对用于天然产物化合物活性筛选的斑马鱼发育筛选进行了综述,并与大家分享目标信号通路的相关信息。任何从表型发育缺陷的斑马鱼胚胎中鉴定出来的能扰乱信号通路的活性化合物都为人类癌症的靶向治疗提供了一个机会。这个模型提供了一个从天然产物中寻找癌症靶向治疗药物的有前途的工具。
关键词: 天然产物,新颖的药物靶点,信号通路,癌症靶向治疗,目标识别,斑马鱼表型分析
图形摘要
Current Cancer Drug Targets
Title:Zebrafish: Predictive Model for Targeted Cancer Therapeutics from Nature
Volume: 14 Issue: 8
Author(s): Nursafwana Syazwani Zulkhernain, Soo Hwang Teo, Vyomesh Patel and Pei Jean Tan
Affiliation:
关键词: 天然产物,新颖的药物靶点,信号通路,癌症靶向治疗,目标识别,斑马鱼表型分析
摘要: Targeted therapy, the treatment of cancer based on an underlying genetic alteration, is rapidly gaining favor as the preferred therapeutic approach. To date, although natural products represent a rich resource of bio-diverse drug candidates, only a few have been identified to be effective as targeted cancer therapies largely due to the incompatibilities to current high-throughput screening methods. In this article, we review the utility of a zebrafish developmental screen for bioactive natural product-based compounds that target signaling pathways that are intimately shared with those in humans. Any bioactive compound perturbing signaling pathways identified from phenotypic developmental defects in zebrafish embryos provide an opportunity for developing targeted therapies for human cancers. This model provides a promising tool in the search for targeted cancer therapeutics from natural products.
Export Options
About this article
Cite this article as:
Nursafwana Syazwani Zulkhernain, Soo Hwang Teo, Vyomesh Patel and Tan Jean Pei, Zebrafish: Predictive Model for Targeted Cancer Therapeutics from Nature, Current Cancer Drug Targets 2014; 14 (8) . https://dx.doi.org/10.2174/1568009614666141028121347
DOI https://dx.doi.org/10.2174/1568009614666141028121347 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry Second Generation Adeno-Associated Virus Type 2-based Gene Therapy Systems with the Potential for Preferential Integration into AAVS1
Current Gene Therapy Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Patent Selections
Recent Patents on Biotechnology Challenges and Opportunities in Molecular Imaging
Current Medical Imaging Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance
Current Pharmaceutical Design N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy
Current Cancer Drug Targets Meet Our Editorial Board Member
Current Drug Discovery Technologies Human Immunodeficiency Virus-Mononuclear Phagocyte Interactions:Emerging Avenues of Biomarker Discovery, Modes of Viral Persistence and Disease Pathogenesis
Current HIV Research Editorial [ Hot Topic: Targeting Tumor Angiogenesis: An Update (Guest Editor: Girolamo Ranieri)]
Current Medicinal Chemistry MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Interaction of Prolyl Oligopeptidase with α-Synuclein
CNS & Neurological Disorders - Drug Targets A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia
Current Medicinal Chemistry High Throughput Determination of Gains and Losses of Genetic Material Using High Resolution BAC Arrays and Comparative Genomic Hybridization
Combinatorial Chemistry & High Throughput Screening Immuno-Isolation in Oncology - A Mini-Review
Current Pharmaceutical Biotechnology Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
Current Genomics Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
Current Pharmaceutical Design